Future Therapies for AML including Mitostory, CPX-351, IDH-1, & IDH-2

Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses several and recent developments in AML treatment at the 58th ASH Annual Meeting in San Diego, CA.